What is your approach to prescribing JAK inhibitors in patients with alopecia areata who have a prior history of cutaneous malignancy, such as DFSP?

For something like DFSP, it would depend on how long it has been since their diagnosis, and a shared decision-making process with the patient. Close monitoring with skin checks would be recommended.